ClinicalTrials.Veeva

Menu

Effects of Vitamin D Supplementation on Antimycobacterial Immunity

B

Barts & The London NHS Trust

Status

Completed

Conditions

Tuberculosis

Treatments

Drug: Ergocalciferol

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine how vitamin D supplementation (ergocalciferol) affects the immune response to mycobacterial infection.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult
  • Tuberculosis (TB) contact or TB patient

Exclusion criteria

  • Pregnancy
  • Breastfeeding
  • Hyperparathyroidism
  • Sarcoidosis
  • Renal failure
  • HIV infection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems